Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Adial Pharmaceuticals, Inc.

NASDAQ: ADILHealthcare / Biotechnology / USA
2.69-0.1400-4.95%Vol 121 8001Y Perf -34.07%
Apr 18th, 2019 16:00
BID2.65 ASK2.69
Open2.80 Previous Close2.83
Pre-Market- After-Trading-
 - -%  - -%
Target Price
5.50 
Analyst Rating
— — 0.00
Potencial %
104.46 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)27 
Earnings Rating
Price Range Ratio 52wk %
18.97 
Earnings Date
3rd Apr 2019

Today's Price Range

2.532.90

 

52wk Range

1.119.44

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-9.73%
3 Months
-59.85%
6 Months
2.28%
1 Year
-34.07%
3 Years
-
5 Years
-

Name / TickerPriceChg.Chg.%
ADIL2.69-0.1400-4.95
AAPL203.860.73000.36
GOOG1 236.370.03000.00
MSFT123.371.60001.31
XOM81.13-0.3000-0.37
WFC47.580.03000.06
JNJ137.52-1.0000-0.72
FB178.28-0.5000-0.28
GE9.350.23002.52
JPM113.46-0.8400-0.73
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
15.00
Current Ratio
18.20
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-9.00
Leverage Ratio 1.60
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.31-0.85-174.19
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume121 800
Shares Outstanding (in ths.)10 144
Trades Count227
Dollar Volume312 543
Avg. Volume469 540
Avg. Weekly Volume91 065
Avg. Monthly Volume107 311
Avg. Quarterly Volume431 305

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

42%58%

Bearish Bullish

62%38%

Bearish Bullish

36%64%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Rating---

There are no comments yet.

News